Drugs Made In America Acquisition LLC

CIK 2038492 · last filed 2025-02-18

Drugs Made In America Acquisition LLC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing, for DMAAU, was dated Feb 18, 2025. Current disclosed insider exposure totals $44.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$44.78M

Companies

1

Total Filings

2

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
DMAAU	10%+ Owner	4,188,780	$10.69	$44.78M	$0	2	2025-02-18

Recent Filings

2 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2025-02-18	DMAAU	Buy (P)	+30,000	$0	EDGAR
2025-02-04	DMAAU	Mixed	−5,698,363	$0	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.